Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc. (EKSO)

Delisted
2 Jul 2026
NASDAQ (CM) NASDAQ (CM)
$
15. 90
-1.74
-9.8639%
$
38.57M Market Cap
- P/E Ratio
- Div Yield
133,570 Volume
-1.29 Eps
$ 17.64
Previous Close
Investors:
Day Range
15.75 18.12
Year Range
2.73 26.56
Want to track EKSO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

EKSO Chart

Applied Digital And The EKSO Transaction: Buy This Clear Story

Applied Digital And The EKSO Transaction: Buy This Clear Story

Applied Digital Corporation is moving from a mixed and hard-to-value structure into two focused businesses with clearer roles, funding paths and investor bases. The cloud separation creates a pure AI infrastructure vehicle while allowing the parent to remain a stable, contract-driven infrastructure operator. The APLD transaction reshapes the valuation logic by separating stable cash flow assets from higher growth but higher risk computing assets.

Seekingalpha | 9 months ago
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 11 months ago
Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates

Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates

Ekso Bionics (EKSO) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to a loss of $1.5 per share a year ago.

Zacks | 11 months ago

Ekso Bionics Holdings, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Carmen McClennon
Carmen McClennon WR Wealth Planners, LLC
1.94 $39 $2.61 -$36.39 -93.31%

Ekso Bionics Holdings, Inc. (EKSO) FAQ

What does "Delisted" mean?

Ekso Bionics Holdings, Inc. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

The last recorded stock split occurred on Jun 02, 2025 with a ratio of 1:15.

What was the last known trading price?

The stock last traded at $15.90 on Jul 02, 2026 before being delisted.

Ekso Bionics Holdings, Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Scott G. Davis CEO
NASDAQ (CM) Exchange
170924104 CUSIP
US Country
53 Employees
25 Mar 2020 Last Dividend
2 Jun 2025 Last Split
16 Jan 2014 IPO Date

Overview

Ekso Bionics Holdings, Inc. is a pioneer in the field of robotic exoskeletons, focusing on designing, developing, selling, and renting a range of exoskeleton products globally. With its operations spanning across the Americas, Germany, Poland, Europe, the Middle East, Africa, and the Asia Pacific, the company caters to both medical and industrial sectors through its two primary segments: EksoHealth and EksoWorks. The EksoHealth segment is dedicated to the medical market, providing innovative solutions for individuals with neurological or physical disabilities, while the EksoWorks segment targets the industrial domain, offering devices that enhance the productivity and safety of able-bodied users performing strenuous repetitive tasks. Founded in 2005 and headquartered in San Rafael, California, Ekso Bionics is at the forefront of wearable bionic technology, aiming to improve human mobility and efficiency through their groundbreaking products.

Products and Services

  • EksoNR
  • A cutting-edge wearable bionic suit and rehabilitation device, the EksoNR is designed to assist physical therapists and physicians in the treatment of patients suffering from acquired brain injury, stroke, and spinal cord injury. Its primary aim is to facilitate and enhance mobility and strength during the rehabilitation process, thereby accelerating patient recovery.

  • Ekso Indego Therapy
  • This adjustable, powered lower-limb exoskeleton is tailored for use in therapy settings. The Ekso Indego Therapy exoskeleton provides support and mobility for individuals undergoing rehabilitation, focusing on improving gait and independence in users with mobility impairments.

  • Ekso Indego Personal
  • As a personal use version of the therapy exoskeleton, the Ekso Indego Personal offers individuals with lower limb paralysis or weakness the opportunity to stand and walk at home and in their communities. It represents a significant step towards personal mobility and independence for individuals with mobility challenges.

  • Ekso Nomad
  • The Ekso Nomad is a power knee ankle foot orthosis designed to offer dynamic support for individuals requiring assistance with lower-limb mobility. It integrates seamlessly into the user’s life, providing a more natural gait pattern and empowering users in their daily activities.

  • Ekso EV
  • Targeting the industrial sector, the Ekso EV is a wearable upper body exoskeleton that supports and elevates a worker's arms for tasks ranging from chest height to overhead positions. This device is engineered to reduce the physical strain on workers performing repetitive tasks and thus, mitigating the risk of work-related injuries while increasing productivity.

Contact Information

Address: 101 Glacier Point
Phone: 510 984 1761